A Popular Decongestant Doesn’t Work. The FDA Is Finally Doing Something About It
Oral phenylephrine was shown to be ineffective for treating nasal congestion over a year go. This week, the FDA took the ...
FDA proposes removing ineffective decongestant found in NyQuil, Benadryl, Sudafed and Mucinex
The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral ...
FiercePharma7d
FDA proposes ban on main ingredient in many OTC decongestants
Common oral medicines that have been used for decades as decongestants such as Sudafed, NyQuil and Benadryl may soon be ...
KTVU5d
FDA wants to pull decongestant found in many cold, allergy medicines
The decongestant in question is phenylephrine, which is found in popular cough and cold products, including Benadryl Allergy Plus Congestion, Sudafed ... taken as a pill or liquid has been ...
‘The biggest scam’: Pharmacist exposes ingredients in ZzzQuil, recommends Dollar Tree version instead
Despite needing FDA clearance to be on the shelves of your local pharmacy, some popular medicines probably don't work.
The cold and flu remedies that REALLY work: As US regulators warn many popular treatments simply don't make a difference, these are the ones that do
At the first sign of a runny nose many people dash out to buy a cold and flu remedy - but soon that might become harder to do ...
KONA6d
FDA Looking to Pull Popular Nasal Congestant Ingredient in 2025
OP is found in, and listed as an active ingredient in many popular medicines, including Advil, NyQuil, Sudafed, Robitussin, ...
FDA wants to pull decongestant found in many cold, allergy medicines
The FDA is proposing the removal of phenylephrine, a popular nasal decongestant, in oral form from over-the-counter use. Here ...
abc7NY7d
FDA moves to pull nasal decongestant in some cold medicines from shelves amid effectiveness concerns
Phenylephrine, found in products like Sudafed PE, Vicks DayQuil and Mucinex Sinus-Max, has been widely used as a nasal decongestant for decades. The FDA's proposal isn't an immediate order ...